Cryo Cell International (CCEL) Payables (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Payables data on file, last reported at $3.5 million in Q1 2026.

• Payables for Q1 2026 came in at $3.5 million, up 19.48% year-over-year; the trailing twelve-month figure through Feb 2026 was $3.5 million (up 19.48% YoY), and the FY2025 annual result was $3.1 million, up 48.8% from the prior year.
• Payables improved to $3.5 million in Q1 2026 per CCEL's latest filing, from $3.1 million in the prior quarter.
• Over five years, Payables peaked at $9.6 million in Q3 2022 and troughed at $657561.0 in Q4 2023.
• A 5-year average of $3.0 million and a median of $2.8 million in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2024: Payables tumbled 69.35% in 2023, then soared 212.18% in 2024.
• A 5-year view of Payables shows it stood at $1.8 million in 2022, then plunged by 62.55% to $657561.0 in 2023, then soared by 212.18% to $2.1 million in 2024, then soared by 48.8% to $3.1 million in 2025, then grew by 14.35% to $3.5 million in 2026.
• Business Quant data shows CCEL's Payables at $3.5 million in Q1 2026, $3.1 million in Q4 2025, and $2.8 million in Q3 2025.